Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Eileen is awarded funding for her research into the tumour microenvironment

A picture of Eileen Parkes next to the Wellcome Trust logo

Dr Eileen Parkes has received a Wellcome Trust Clinical Research Career Development Fellowship. This prestigious and highly competitive award will support Eileen and her team with their research into the tumour microenvironment of highly chromosomally unstable oesophageal adenocarcinomas. These aggressive cancers have constitutive cGAS activation, and Eileen, her team and collaborators will model this using novel cell lines and organoids (including fibroblast and immune-cell co-cultures) to understand how this signalling axis impacts the formation of extracellular matrix and subsequent immune infiltration. By unpicking this mechanism, it is hoped that new anti-cancer targets will be identified.

 

I’m really excited about this work – there is an urgent need to improve how we treat oesophageal cancer, and this work will improve our understanding of the underlying mechanisms driving treatment resistance and disease progression, and hopefully identify new drug targets we can use against this aggressive disease .

- Eileen Parkes 

 You can read more about the Wellcome Trust and their mission here (opens in the new window).

Similar stories

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.

Researchers develop easy-to-deploy federated learning system that safeguards patient data

The technique, which builds on recent advances in decentralised machine learning, uses inexpensive pre-programmed micro-computers, making it easy to deploy in hospitals and cheap to scale up.

Festive Science Image Competition Winners

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.